Results 311 to 320 of about 3,179,085 (408)

Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern. [PDF]

Front Oncol
Kim K, Kim Y, Kim SH, Moon JH, Kim EH, Lee EJ, Oh CM, Ku CR.   +7 more
europepmc   +1 more source

Association Between Plasma SITH‐1 Antibody Titers and Treatment Trajectory of Treatment‐Resistant Depression

Neuropsychopharmacology Reports, Volume 45, Issue 4, December 2025.
This study investigated whether SITH‐1, a latent HHV‐6B protein that promotes neuroinflammation, is associated with the clinical trajectory of treatment‐resistant depression (TRD). We demonstrated significantly elevated SITH‐1 titers and a correlation with the number of depressive episodes, suggesting that SITH‐1 may serve as a novel biomarker for TRD.
Keisuke Mori, Fumitoshi Kodaka, Junpei Ishii, Naomi Oka, Kazuhiro Kondo, Shinsuke Kito   +5 more
wiley   +1 more source

Establishment of a risk prediction model for olfactory disorders in patients with transnasal pituitary tumors by machine learning. [PDF]

Sci Rep
Chen M, Li Y, Zhou S, Zou L, Yu L, Deng T, Rong X, Shao S, Wu J.   +8 more
europepmc   +1 more source

Membrane proeteins as markers for normal and neoplastic endocrine cells [PDF]

, 1993
Gratzl, Manfred, Lahr, G., Wagener, Christoph   +2 more
core  

Radiomic Analysis in Pituitary Tumors: Current Knowledge and Future Perspectives. [PDF]

J Clin Med
Bioletto F, Prencipe N, Berton AM, Aversa LS, Cuboni D, Varaldo E, Gasco V, Ghigo E, Grottoli S.   +8 more
europepmc   +1 more source